MicroPort CardioFlow Medtech (HKSE:02160) Total Inventories : HK$134.4 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is MicroPort CardioFlow Medtech Total Inventories?

MicroPort CardioFlow Medtech's total inventories for the quarter that ended in Dec. 2023 was HK$134.4 Mil. MicroPort CardioFlow Medtech's average total inventories from the quarter that ended in Jun. 2023 to the quarter that ended in Dec. 2023 was HK$128.4 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. MicroPort CardioFlow Medtech's Net-Net Working Capital per share for the quarter that ended in Dec. 2023 was HK$0.44.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. MicroPort CardioFlow Medtech's Days Inventory for the six months ended in Dec. 2023 was 461.01.

Inventory Turnover measures how fast the company turns over its inventory within a year. MicroPort CardioFlow Medtech's Inventory Turnover for the quarter that ended in Dec. 2023 was 0.40.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. MicroPort CardioFlow Medtech's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 0.73.

MicroPort CardioFlow Medtech Total Inventories Historical Data

The historical data trend for MicroPort CardioFlow Medtech's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MicroPort CardioFlow Medtech Total Inventories Chart

MicroPort CardioFlow Medtech Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Inventories

Get a 7-Day Free Trial

54.77

80.34

101.30

127.43

134.39

MicroPort CardioFlow Medtech Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Inventories	Get a 7-Day Free Trial					101.30	128.32	127.43	122.37	134.39

MicroPort CardioFlow Medtech Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

MicroPort CardioFlow Medtech (HKSE:02160) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

MicroPort CardioFlow Medtech's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2023 is

	Net-Net Working Capital Per Share (Q: Dec. 2023 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(1164.967	+	0.75 * 110.468	+	0.5 * 134.394	-	264.962
-	0	-	0)	/	2412.48
=	0.44

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

MicroPort CardioFlow Medtech's Days Inventory for the six months ended in Dec. 2023 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Dec. 2023 )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
	=	128.3815	/	50.822	*	365 / 2
	=	461.01

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

MicroPort CardioFlow Medtech's Inventory Turnover for the quarter that ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Dec. 2023 )	/	Average Total Inventories (Q: Dec. 2023 )
	=	50.822	/	128.3815
	=	0.40

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

MicroPort CardioFlow Medtech's Inventory to Revenue for the quarter that ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	128.3815	/	174.756
	=	0.73

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

MicroPort CardioFlow Medtech Total Inventories Related Terms

Thank you for viewing the detailed overview of MicroPort CardioFlow Medtech's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

MicroPort CardioFlow Medtech (HKSE:02160) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroPort CardioFlow Medtech Corp (HKSE:02160) » Definitions » Total Inventories

Comparable Companies

Traded in Other Exchanges

72X:Germany

Address

No. 1601 Zhangdong Road, Zhangjiang Hi-Tech Park, Pudong New District, Shanghai, CHN, 201203

Website

https://www.cardioflowmedtech.com

MicroPort CardioFlow Medtech Corp is a medical device company in China focusing on the research, development, and commercialization of transcatheter and surgical solutions for valvular heart diseases. The company's product portfolio consists of three products VitaFlow, VitaFlow Liberty, and Alwide Plus, and various TAVI products, TMV products, TTV products, surgical valve products, and procedural accessories. Geographically, it derives a majority of its revenue from China.

Executives

China Renaissance Holdings Limited	2201 Interest of corporation controlled by you
Hua Jie Tian Jin Yi Liao Tou Zi He Huo Qi Ye You Xian He Huo	2201 Interest of corporation controlled by you
Shang Hai Hua Hao Qi Ye Guan Li He Huo Qi Ye You Xian He Huo	2101 Beneficial owner
Tian Jin Hua Jie Qi Ye Guan Li Zi Xun He Huo Qi Ye You Xian He Huo	2201 Interest of corporation controlled by you
Tian Jin Hua Qing Qi Ye Guan Li Zi Xun You Xian Gong Si	2201 Interest of corporation controlled by you
Microport Scientific Corporation	2201 Interest of corporation controlled by you
Shanghai Microport Limited	2101 Beneficial owner
China International Capital Corporation Limited	2201 Interest of corporation controlled by you
Cicc Capital Management Co., Ltd.	2201 Interest of corporation controlled by you
Cicc Kangrui I (ningbo) Equity Investment Limited Partners (limited Partnership)	2101 Beneficial owner
Cicc Kangzhi (ningbo) Equity Investment Management Co., Ltd.	2201 Interest of corporation controlled by you

MicroPort CardioFlow Medtech (HKSE:02160) Headlines

No Headlines